SECOND AMENDMENT TO ASSET PURCHASE AGREEMENTAsset Purchase Agreement • November 10th, 2016 • DanDrit Biotech USA, Inc. • Pharmaceutical preparations • Delaware
This Second Amendment to Asset Purchase Agreement (this “Amendment”) is entered into as of November 9, 2016 with respect to the Asset Purchase Agreement dated as of April 4th, 2016 (the “Original Agreement”) by and between OncoSynergy Inc., a Delaware corporation (“OS”) and DanDrit BioTech USA Inc., a Delaware corporation (“DanDrit”). Each of the parties to this Agreement is individually referred to herein as a “Party” and collectively as the “Parties”. Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Original Agreement.
